Basics Guardant Health, Inc. IPO Date: October 1, 2018 Sector: Healthcare Industry: Diagnostics and Research Market Cap: $13.25B Activated in VL: True Average Daily Range Avg Daily Range: $1.69 | 2.78% Avg Daily Range (30 D): $2.37 | 2.49% Avg Daily Range (90 D): $1.63 | 2.29% Institutional Daily Volume Avg Daily Volume: 1.32M Avg Daily Volume (30 D): 2.78M Avg Daily Volume (90 D): 2.45M Trade Size Avg Trade Size (Sh.): 69 Avg Trade Size (Sh.) (30 D): 59 Avg Trade Size (Sh.) (90 D): 59 Institutional Trades Total Inst.Trades: 8,116 Avg Inst. Trade: $3.16M Avg Inst. Trade (30 D): $4.03M Avg Inst. Trade (90 D): $3.73M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 4 Market Closing Trades Avg Closing Trade: $6.93M Avg Closing Trade (30 D): $20.86M Avg Closing Trade (90 D): $17.84M Avg Closing Volume: 134.25K     News Nov 28, 2025 @ 1:00 PM Pre-Dx Oncology Market Outlook 2026–2035: A... Source: Towards Healthcare Nov 21, 2025 @ 4:00 PM Oncology Biomarker Market Accelerates Toward USD 1... Source: Towards Healthcare Nov 18, 2025 @ 2:00 PM Breast Cancer Screening Tests Market to Reach USD ... Source: Towards Healthcare Oct 22, 2025 @ 6:26 PM Molecular Diagnostics Market to Grow at 13.1% CAGR... Source: Bcc Research Aug 22, 2025 @ 1:00 PM Global Liquid Biopsy Market Set to Reach USD 7.05 ... Source: Marketsandmarkets Financials   TTM Q2 2025 Q1 2025 Basic EPS $-3.35 $-.8 $-.77 Diluted EPS $-3.35 $-.8 $-.77 Revenue $ 828.85M $ 232.09M $ 203.47M Gross Profit $ $ 150.88M $ 128.75M Net Income / Loss $ -413.82M $ -99.9M $ -95.16M Operating Income / Loss $ -460.75M $ -106.41M $ -111.04M Cost of Revenue $ $ 81.21M $ 74.72M Net Cash Flow $ -297.99M $ -68.37M $ 174.1M PE Ratio